GeneHealth - Your precision medicine

Dracunculiasis

Disease Details

Family Health Simplified

Buy Membership

Description: Dracunculiasis, also known as Guinea worm disease, is a parasitic infection caused by the nematode Dracunculus medinensis, leading to painful, burning ulcers typically on the lower limbs.
Type: Dracunculiasis, also known as guinea worm disease, is a parasitic infection. It is not genetically transmitted, as it is acquired through the ingestion of water contaminated with water fleas (Cyclops species) that carry the larvae of the parasite Dracunculus medinensis.
Signs And Symptoms: The first signs of dracunculiasis occur around a year after infection, as the full-grown female worm prepares to leave the infected person's body. As the worm migrates to its exit site – typically the lower leg – some people have allergic reactions, including hives, fever, dizziness, nausea, vomiting, and diarrhea. Upon reaching its destination, the worm forms a fluid-filled blister under the skin. Over 1–3 days, the blister grows larger, begins to cause severe burning pain, and eventually bursts leaving a small open wound. The wound remains intensely painful as the worm slowly emerges over several weeks to months.If an affected person submerges the wound in water, the worm spews a white substance releasing its larvae into the water. As the worm emerges, the open blister often becomes infected with bacteria, resulting in redness and swelling, the formation of abscesses, or in severe cases gangrene, sepsis or lockjaw. When the secondary infection is near a joint (typically the ankle), the damage to the joint can result in stiffness, arthritis, or contractures.Infected people commonly harbor multiple worms – on average 1.8 worms per person, but as many as 40 – which will emerge from separate blisters at the same time. 90% of worms emerge from the legs or feet. However, worms can emerge from anywhere on the body.
Prognosis: Dracunculiasis, also known as Guinea worm disease, has a favorable prognosis if the emerging worm is carefully extracted and no secondary infections occur. However, it can be debilitating during the active infection phase, causing significant pain and potentially leading to secondary bacterial infections and complications. The disease is not usually fatal, but it can lead to temporary disability. Nan refers to nanotechnology or nanoparticles, but there are currently no nanotechnology-based treatments specifically for dracunculiasis. The primary treatment involves careful mechanical removal of the worm and wound care to prevent infections.
Onset: Dracunculiasis, also known as Guinea worm disease, typically has an incubation period of about 10-14 months from the time of infection until symptoms appear. NAN (Not Applicable/Not Available) information is not needed for this context.
Prevalence: Dracunculiasis, or Guinea worm disease, is nearing eradication with significant reductions in prevalence. In 2022, there were only 13 reported cases globally, mainly confined to Chad and a few cases in Ethiopia, Mali, and South Sudan. The near eradication is the result of extensive public health campaigns aimed at water sanitation and health education.
Epidemiology: Dracunculiasis is nearly eradicated, with just 14 cases reported worldwide in 2023 and 13 in 2022. This is down from 27 cases in 2020, and dramatically less than the estimated 3.5 million annual cases in 20 countries in 1986 – the year the World Health Assembly called for dracunculiasis' eradication. Dracunculiasis remains endemic in just four countries: Chad, Ethiopia, Mali, and South Sudan.Dracunculiasis is a disease of extreme poverty, occurring in places where there is poor access to clean drinking water. Cases tend to be split roughly equally between males and females, and can occur in all age groups. Within a given place, dracunculiasis risk is linked to occupation; people who farm or fetch drinking water are most likely to be infected.Cases of dracunculiasis have a seasonal cycle, though the timing varies by location. Along the Sahara desert's southern edge, cases peak during the mid-year rainy season (May–October) when stagnant water sources are more abundant. Along the Gulf of Guinea, cases are more common during the dry season (October–March) when flowing water sources dry up.
Intractability: Dracunculiasis, also known as Guinea worm disease, is not entirely intractable. Significant progress has been made in eradicating the disease through public health interventions, including safe drinking water provision and education on prevention. Cases have drastically decreased, and it is on the verge of eradication. However, the disease can be challenging to control in certain endemic areas due to factors like remote locations and cultural practices.
Disease Severity: Dracunculiasis, also known as Guinea worm disease, is a parasitic infection that primarily affects individuals in isolated, rural communities lacking access to safe drinking water. Here is the information:

**Disease Severity**: Dracunculiasis can cause significant morbidity but is rarely fatal. The infection leads to painful blister formation and can result in severe inflammation, secondary bacterial infections, and temporary or permanent disability. The adult female worm emerging from the skin can incapacitate a person for weeks to months. Despite its debilitating effects, it has a low mortality rate.

**NAN**: N/A (Usually stands for Not Applicable or Not Available, but not relevant in this context)
Healthcare Professionals: Disease Ontology ID - DOID:14418
Pathophysiology: Dracunculiasis, also known as guinea worm disease, is caused by the parasitic worm Dracunculus medinensis. The pathophysiology involves the following steps:

1. **Ingestion**: Human infection begins when a person drinks stagnant water containing copepods (water fleas) infected with guinea worm larvae.
2. **Larvae Release**: The copepods die in the stomach, releasing the larvae, which then penetrate the stomach or intestinal wall into the body cavity.
3. **Maturation**: Inside the body, the larvae mature and mate. Male worms die after mating, while fertilized female worms grow.
4. **Migration**: Over the course of a year, the female worms migrate through connective tissues, usually towards the lower limbs.
5. **Blister Formation**: When the worm is ready to release larvae, it induces a painful blister on the skin's surface.
6. **Worm Emergence**: The blister ruptures, causing a burning sensation, which often prompts the infected person to immerse the affected area in water. Contact with water triggers the worm to release larvae, restarting the cycle.

The disease primarily causes severe pain, secondary bacterial infections, and long-term disabilities due to the emergence of the worms and associated complications.
Carrier Status: Dracunculiasis, also known as Guinea worm disease, is not associated with a carrier status in the traditional sense, as it requires a specific lifecycle involving both humans and water fleas (Cyclops species). Humans become infected by drinking water contaminated with these infected water fleas. There are no asymptomatic carriers; the disease is characterized by the emergence of the adult female worm, which typically causes painful ulcers.
Mechanism: Dracunculiasis, also known as Guinea worm disease, is caused by the parasitic worm *Dracunculus medinensis*.

**Mechanism:**

1. **Transmission:**
- Humans become infected by drinking water contaminated with copepods (water fleas) that harbor infective larvae of the *Dracunculus medinensis* worm.

2. **Development:**
- After ingestion, the copepods die, releasing larvae, which then penetrate the host's stomach and intestinal walls, entering the abdominal cavity and retroperitoneal space.
- The larvae mature into adult worms, with males typically dying after mating and females continuing to grow to a length of up to 3 feet (1 meter).

3. **Migration:**
- Approximately one year after infection, the mature female worm travels to the surface of the skin, usually on the lower limbs.
- A blister forms at the site, which eventually ruptures, often causing unbearable burning pain.

4. **Emergence and Lifecycle Continuation:**
- To relieve pain, affected individuals often immerse the area in water, prompting the worm to release its larvae into the water.
- These larvae are then ingested by copepods, continuing the cycle.

**Molecular Mechanisms:**

- While the detailed molecular mechanisms of *Dracunculus medinensis* and host interactions are not fully understood, several key points are known:
- **Immune Evasion:** The parasite produces molecules that help it evade the host's immune system, allowing it to survive within the host tissue for an extended period.
- **Penetration and Migration:** Proteolytic enzymes are likely involved in the larval penetration of the host gastrointestinal wall and subsequent migration through body tissues.
- **Blister Formation:** The exact molecular signals involved in blister formation are not fully delineated, but it is related to the worm releasing larvae and possibly other compounds that induce local inflammation and skin tissue breakdown.

Efforts to better understand these mechanisms are ongoing and contribute to the strategies for eradicating this debilitating disease.
Treatment: There is no medicine to kill D. medinensis or prevent it from causing disease once within the body. Instead, treatment focuses on slowly and carefully removing the worm from the wound over days to weeks. Once the blister bursts and the worm begins to emerge, the wound is soaked in a bucket of water, allowing the worm to empty itself of larvae away from a source of drinking water. As the first part of the worm emerges, it is typically wrapped around a piece of gauze or a stick to maintain steady tension on the worm, encouraging its exit. Each day, several centimeters of the worm emerge from the blister, and the stick is wound to maintain tension. This is repeated daily until the full worm emerges, typically within a month. If too much pressure is applied at any point, the worm can break and die, leading to severe swelling and pain at the site of the ulcer.Treatment for dracunculiasis also includes regular wound care to avoid infection of the open ulcer while the worm is leaving. The U.S. Centers for Disease Control and Prevention (CDC) recommends cleaning the wound before the worm emerges. Once the worm begins to exit the body, the CDC recommends daily wound care: cleaning the wound, applying antibiotic ointment, and replacing the bandage with fresh gauze. Painkillers like aspirin or ibuprofen can help ease the pain of the worm's exit.
Compassionate Use Treatment: For dracunculiasis (Guinea worm disease), there are no specific compassionate use treatments or common off-label/experimental treatments, as the primary approach focuses on prevention and supportive care. The standard treatment involves:

1. **Manual Extraction:** The live worm is slowly and carefully extracted over several days or weeks by winding it around a small stick or gauze to avoid breaking it.

2. **Pain Management:** Pain relief can be provided through analgesics and anti-inflammatory medications.

Efforts are primarily concentrated on prevention through measures such as providing safe drinking water, educating affected communities, and using filters to remove the larvae from drinking water. As the disease is on the verge of eradication, specific treatments beyond current methods are generally unnecessary.
Lifestyle Recommendations: For dracunculiasis (Guinea worm disease), lifestyle recommendations to prevent infection include:

1. **Water Safety**: Always drink water from clean, safe sources. Use well-maintained wells or piped water. If only unsafe sources are available, filter water using fine-mesh cloth, nylon filters, or portable water filters designed to block the larvae.

2. **Avoid Contaminated Water**: Do not walk into or wade through stagnant water bodies that could be contaminated with Guinea worm larvae, especially during the rainy season when these conditions are common.

3. **Health Education**: Participate in community education programs that inform about the risks of contaminated water and encourage safe water practices.

4. **Community Cooperation**: Support efforts to provide safe water supplies and report any cases of Guinea worm disease to local health authorities to help control and prevent the spread within the community.

5. **Protective Footwear**: Wear shoes to avoid contact with contaminated soil or water, especially in known endemic areas.

6. **Containment Measures**: If infected, prevent the spread by not bathing or swimming in communal water sources. Follow medical advice to contain the infection.

These measures are crucial in the fight to eradicate dracunculiasis and protect public health.
Medication: There are no specific medications approved for treating dracunculiasis, also known as Guinea worm disease. The primary treatment involves the gradual removal of the worm by winding it around a small stick or piece of gauze. This process can take several days to weeks. Management also includes cleaning and bandaging the affected area to prevent secondary infections and ensuring the patient has supportive care.
Repurposable Drugs: There are no known repurposable drugs for the treatment of dracunculiasis (Guinea worm disease). The primary method of managing dracunculiasis involves careful manual extraction of the worm and wound care to prevent secondary infections.
Metabolites: Dracunculiasis, also known as Guinea worm disease, primarily involves the parasitic worm Dracunculus medinensis. There are no specific metabolites associated with the worm that are commonly measured or targeted in diagnosis and treatment. The disease is identified through the emergence of the adult female worm from the skin, and treatment typically involves the manual extraction of the worm. Preventative measures are focused on improving water sources and educating vulnerable populations. Nanotechnology is not currently a standard part of managing dracunculiasis.
Nutraceuticals: For dracunculiasis, there are no established nutraceuticals specifically for treating or preventing the disease. Dracunculiasis, also known as Guinea worm disease, is primarily addressed through preventive measures such as providing safe drinking water, health education, and the filtering of water to remove copepods that carry Dracunculus medinensis larvae. The disease requires careful extraction of the worm from the body once symptoms appear. Nutraceuticals do not play a significant role in the current management or prevention strategies for dracunculiasis.
Peptides: Dracunculiasis, also known as Guinea worm disease, is caused by the parasitic worm Dracunculus medinensis. The infection typically occurs when people consume water contaminated with water fleas (Cyclops) that harbor the larvae. After ingestion, the larvae penetrate the host's stomach and intestinal wall, mature into adult worms, and migrate through the body. Eventually, the female worm emerges through the skin, often in the lower limbs, causing painful ulcers.

Unfortunately, there is no direct treatment involving peptides or nanotechnology specifically for dracunculiasis at this time. Control and eradication strategies focus on preventative measures such as providing safe drinking water, health education, and the use of filters to remove water fleas from drinking water. The physical removal of the worm by carefully winding it around a stick remains a standard procedure for managing the condition once the worm begins to emerge from the skin.